Yun Taeyoung, Kim Ji Seong, Kang Yoonjin, Sohn Suk Ho, Hwang Ho Young
Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.
Ann Thorac Surg Short Rep. 2023 Apr 14;1(3):396-400. doi: 10.1016/j.atssr.2023.04.001. eCollection 2023 Sep.
This study was conducted to evaluate whether the in situ right internal thoracic artery (RITA) can be an effective alternative to the left internal thoracic artery (LITA) as a single-inflow source in coronary artery bypass grafting (CABG).
Between 2006 and 2018, 73 patients underwent CABG with the composite grafting based on the in situ RITA as a single-inflow source (the RITA group). Angiographic patency and clinical outcomes were evaluated. These were compared with results after CABG using the composite grafting based on the in situ LITA (the LITA group) by 1:1 propensity score matching.
Forty-three pairs were extracted by 1:1 propensity score matching. There were no significant intergroup differences in overall patency rates between the RITA and LITA groups at 1 year (92.2% [95/103] and 92.5% [111/120], respectively; = .90) and 5 years (87.3% [48/55] and 90.4% [85/94], respectively; = .58). There were no significant differences in the cumulative incidences of reintervention and major adverse cardiac events between the 2 groups (hazard ratio, 2.0 [95% CI, 0.33-11.97] and 1.50 [0.41-5.45], respectively).
Five-year graft patency and long-term clinical outcomes after CABG using the composite grafting based on the in situ RITA were not significantly different from those after CABG using the LITA.
本研究旨在评估在冠状动脉旁路移植术(CABG)中,原位右胸廓内动脉(RITA)作为单一血流来源替代左胸廓内动脉(LITA)的有效性。
2006年至2018年期间,73例患者接受了以原位RITA作为单一血流来源的复合移植CABG(RITA组)。评估血管造影通畅率和临床结局。通过1:1倾向评分匹配,将这些结果与使用原位LITA的复合移植CABG术后结果(LITA组)进行比较。
通过1:1倾向评分匹配提取了43对。RITA组和LITA组在1年时的总体通畅率(分别为92.2%[95/103]和92.5%[111/120];P = 0.90)以及5年时(分别为87.3%[48/55]和90.4%[85/94];P = 0.58)均无显著组间差异。两组在再次干预和主要不良心脏事件的累积发生率方面无显著差异(风险比分别为2.0[95%CI,0.33 - 11.97]和1.50[0.41 - 5.45])。
使用基于原位RITA的复合移植进行CABG术后的5年移植通畅率和长期临床结局与使用LITA进行CABG术后的结果无显著差异。